Clinical data | |
---|---|
Trade names | Rheumox |
AHFS/ Drugs.com | International Drug Names |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 20 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.033.543 |
Chemical and physical data | |
Formula | C16H20N4O2 |
Molar mass | 300.362 g·mol−1 |
3D model ( JSmol) | |
Chirality | Racemic mixture |
| |
| |
NY (what is this?) (verify) |
Azapropazone is a nonsteroidal anti-inflammatory drug (NSAID). It is manufactured by Goldshield under the tradename Rheumox. [1]
It was available in the UK as a prescription-only drug, with restrictions due to certain contra-indications and side-effects. [2] Azopropazone has now been discontinued in the British National Formulary.
Azapropazone has a half-life of approximately 20 hours in humans and is not extensively metabolized. [3]
pyrazolones / pyrazolidines | |
---|---|
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives ( profens) |
|
n-arylanthranilic acids ( fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #
WHO-Essential Medicines; †
withdrawn drugs; ‡
veterinary use. | |
Receptor ( ligands) |
| ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Enzyme ( inhibitors) |
| ||||||||||||||||||||||||||
Others | |||||||||||||||||||||||||||
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |